Humanigen Inc (fka HGENQ)

[DonDonDonDon]

Did not specifically discuss HGEN or other drugs still in trials.

I was hoping that she would mention GM-CSF. But the UK trial is brand spanking new. While Woodcock is surely studying GM-CSF right now, she isn't going to talk about it publicly only one week after the study was published. New science moves more slowly than investors would like it to move. It is actually too bad that the UK study didn't come out a few months ago. It confirms that the trial is likely a success but it hasn't affected the stock price much, yet.